Malignant hyperthermia: A syndrome not a disease

Veterinary Clinics of North America - Small Animal Practice

Volumn 34, Issue 6 SPEC.ISS., 2004, Pages 1419-1433

  Brunson, David B ^a   Hogan, Kirk J ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDROPYRIDINE RECEPTOR; ACEPROMAZINE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CARBON DIOXIDE; DANTROLENE; DETOMIDINE; DIAZEPAM; ETOMIDATE; HALOTHANE; INTRAVENOUS ANESTHETIC AGENT; ISOFLURANE; LIDOCAINE; LOCAL ANESTHETIC AGENT; MEDETOMIDINE; MIDAZOLAM; NARCOTIC ANALGESIC AGENT; NEUROMUSCULAR BLOCKING AGENT; NITROUS OXIDE; OPIATE DERIVATIVE; OXYGEN; PHENOTHIAZINE; PROCAINAMIDE; PROPOFOL; RYANODINE RECEPTOR; SEVOFLURANE; SUXAMETHONIUM; THIOPENTAL; UNINDEXED DRUG; XYLAZINE;

ALERTNESS; ANESTHESIOLOGICAL TECHNIQUES; ANIMAL DISEASE; ARTERIAL CARBON DIOXIDE TENSION; ARTICLE; ARTIFICIAL VENTILATION; BODY TEMPERATURE DISORDER; CAT DISEASE; CONVALESCENCE; CORE TEMPERATURE; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE SEVERITY; DOG DISEASE; DRUG SAFETY; END TIDAL CARBON DIOXIDE TENSION; GENE MUTATION; GENERAL ANESTHESIA; HEART ARRHYTHMIA; HISTORY OF MEDICINE; HORSE DISEASE; HYPERKALEMIA; LETHALITY; MALIGNANT HYPERTHERMIA; MONITORING; MORTALITY; MUSCLE NECROSIS; NEUROMUSCULAR DISEASE; NONHUMAN; PAIN; PRIVATE PRACTICE; QUALITY OF LIFE; STATISTICAL ANALYSIS; SWINE DISEASE; TEMPERATURE MEASUREMENT; TREATMENT PLANNING; VETERINARY MEDICINE;

ANIMALIA; CANIS FAMILIARIS; EQUIDAE; FELIS CATUS;

EID: 5044250011     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvsm.2004.05.010     Document Type: Review

References (57)

1. H. Ørding Epidemiology of malignant hyperthermia In: J. Schulte am Esch J. Scholz F. Wappler editors. Malignant hyperthermia 2000 Pabst Science Publishers Lengerich 26-29
2. M.C. Roberts J.R. Mickelson E.E. Patterson et al. Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel Anesthesiology 95 2001 716-725
3. K.T. Jurkat-Rott T. McCarthy F. Lehmann-Horn Genetics and pathogenesis of malignant hyperthermia Muscle Nerve 23 2000 4-17
4. M.C. Berman G.G. Harrison P. Dutoit et al. Halothane induced hyperpyrexia in landrace pigs S Afr Med J 43 1969 545-546
5. A.H. Kirmayer A.M. Klide J.E. Puvance Malignant hyperthermia in a dog: case report and review of the syndrome J Am Vet Med Assoc 185 1984 978-982
6. D.C. Sawyer Malignant hyperthermia J Am Vet Med Assoc 179 1981 341-344
7. R.H. De Jong J.E. Hoarner D.W. Amory Malignant hyperthermia in the cat Anesthesiology 41 1974 608-609
8. J.R. Bellah S.A. Robertson C.D. Buergelt et al. Suspected malignant hyperthermia after halothane anesthesia in a cat Vet Surg 18 1989 483-488
9. D.H. Riedesel S.V. Hildebrand Unusual response following use of succinylcholine in a horse anesthetized with halothane J Am Vet Med Assoc 187 1985 507-508
10. L.V. Klein A hot horse Vet Anesth 2 1975 41-42
11. A.S. Fairhurst V. Hamamoto J. Macri Modification of ryanodine toxicity by dantrolene and halothane in a model of malignant hyperthermia Anesthesiology 53 3 1980 199-204
12. J.R. Mickelson E.M. Gallant L.A. Litterer et al. Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia J Biol Chem 263 1988 9310-9315
13. K. Hogan R.G. Gregg P.A. Powers The structure of the gene encoding the human skeletal muscle α1 subunit of the dihydropyridine-sensitive L-type calcium channel (CACNL1A3) Genomics 31 1996 392-394
14. S.L. Stewart K. Hogan H. Rosenberg J.E. Fletcher Identification of the Arg1086 His mutation in the alpha subunit of the voltage-dependent calcium channel (CACNA1S) in a North American family with malignant hyperthermia Clin Genet 59 2001 178-184
15. R. Moslehi S. Langlois I. Yam J.M. Friedman Linkage of malignant hyperthermia and hyperkalemic periodic paralysis to the adult skeletal muscle sodium channel xv(SCN4A) gene in a large pedigree Am J Med Genet 76 1 1998 21-27
16. L. Missiaen W. Robberecht L. van den Bosch et al. Abnormal intracellular Ca2+ homeostasis and disease Cell Calcium 28 1 2000 1-21
17. Y.A. Rajabally M. El Lahawi Hypokalemic periodic paralysis associated with malignant hyperthermia Nerve Muscle 25 2002 453-455
18. R.L. Robinson C. Brooks S.L. Brown et al. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes Hum Mutat 20 2 2002 88-89
19. N. Monnier N.B. Romero J. Lerale et al. Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor Hum Mol Genet 10 22 2001 2581-2592
20. R.M. Fricker T. Raffelsberger S. Rauch-Schorny et al. Positive malignant hyperthermia susceptibility in vitro in a patient with mitochondrial myopathy and myoadenylate deaminase deficiency Anesthesiology 97 6 2002 1635-1637
21. C. Schneider F. Pedrosa Gil M. Schneider et al. Intolerance to neuroleptics and susceptibility for malignant hyperthermia in a patient with proximal myotonic myopathy (PROMM) and schizophrenia Neuromuscul Disord 12 2002 31-35
22. F. Wappler M. Fiege M. Steinfath et al. Evidence for susceptibility to malignant hyperthermia in patients with exercised-induced rhabdomyolysis Anesthesiology 94 1 2001 95-100
23. M. Davis R. Brown A. Dickson et al. Malignant hyperthermia associated with exercise-induced rhabdomyolysis or congenital abnormalities and a novel RYR1 mutation in New Zealand and Australian pedigrees Br J Anaesth 88 2002 508-515
24. J.R. Tobin D.R. Jason V.R. Challa et al. Malignant hyperthermia and apparent heat stroke JAMA 286 2 2001 168-169
25. K. Hogan The anesthetic myopathies and malignant hyperthermias Curr Opin Neurol 11 1998 469-476
26. A. Houde S.A. Pommier Use of polymerase chain reaction technology to detect a mutation associated with malignant hyperthermia in different pig tissues Meat Sci 33 1993 349-358
27. J. Fujii K. Otsu F. Zorzato et al. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia Science 253 1991 448-451
28. J.E. Fletcher L. Tripolitis M. Hubert et al. Genotype and phenotype relationship for mutations in the ryanodine receptor in patients referred for diagnosis of malignant hyperthermia Br J Anaesth 75 1995 307-310
29. M.S. Claxton-Gill J.L. Cornick-Seahorn J.C. Gamboa B.S. Boatright Suspected malignant hyperthermia syndrome in a miniature pot-bellied pig anesthetized with isoflurane J Am Vet Med Assoc 203 10 1993 1434-1436
30. S.S. Young P.M. Taylor Factors influencing the outcome of equine anaesthesia: a review of 1,314 cases Equine Vet J 25 1993 147-151
31. J.E. Bailey L. Pablo J.A.E. Hubbell Hyperkalemic periodic paralysis episode during halothane anesthesia in a horse J Am Vet Med Assoc 208 11 1996 1859-1865
32. S.V. Hildebrand G.A. Howitt Succinylcholine infusion associated with hyperthermia in ponies anesthetized with halothane Am J Vet Res 44 1983 2280-2284
33. S.V. Manley A.B. Kelly D. Hodgson Malignant hyperthermia-like reactions in three anesthetized horses J Am Vet Med Assoc 183 1983 85-89
34. E. Waldron-Mease H. Rosenberg Post anesthetic myositis in the horse associated with in vitro malignant hyperthermia susceptibility Vet Sci Commun 3 1979 45-50
35. E. Waldron-Mease L.V. Klein H. Rosenberg M. Leitch Malignant hyperthermia in a halothane-anesthetized horse J Am Vet Med Assoc 179 1981 896-898
36. J.J. McClure Malignant hyperthermia in the horse: a case report Minn Vet 15 11 1975 12-47
37. T.E. Nelson Malignant hyperthermia in dogs J Am Vet Med Assoc 198 6 1991 989-994
38. S. Cosgrove P. Eisele R. Martucci G. Gronert Evaluation of Greyhound susceptibility to malignant hyperthermia using halothane-succinylcholine anesthesia and caffeine-halothane muscle contractures Lab Anim Sci 42 1992 482-485
39. P.J. O'Brien P.H. Cribb R.J. White et al. Canine malignant hyperthermia: diagnosis of susceptibility in a breeding colony Can Vet J 24 1983 172-177
40. C.J. McGrath A.J. Crimi J. Ruff Malignant hyperthermia in dogs VM SAC 77 1982 218-220
41. P.J. O'Brien H.A. Pook A. Klip et al. Canine stress syndrome/malignant hyperthermia susceptibility: calcium-homeostasis defect in muscle and lymphocytes Res Vet Sci 48 1990 124-128
42. P.J. O'Brien Canine malignant hyperthermia/canine stress syndrome In: Malignant hyperthermia 1994 CRC Press Boca Raton 105-116
43. C.E. Short R.R. Paddleford Malignant hyperthermia in the dog Anesthesiology 39 1973 462-463
44. R.J. Bagshaw R.H. Cox D.H. Knight et al. Malignant hyperthermia in a Greyhound J Am Vet Med Assoc 172 1978 61-62
45. K. Otto Maligne hyperthermia als Narkosekomplikation beim hund Tierarztl Prax 20 1992 519-522
46. P.J. Dickinson M. Sullivan Exercise induced hyperthermia in a racing Greyhound [letter] Vet Rec 135 1994 508
47. S.L. Leary L.C. Anderson P.J. Manning R.J. Bache B.A. Zweber Recurrent malignant hyperthermia in a Greyhound J Am Vet Med Assoc 182 1983 521-522
48. J.S. Rand P.J. O'Brien Exercise-induced malignant hyperthermia in an English Springer Spaniel J Am Vet Med Assoc 190 1987 1013-1014
49. K.L. Duncan W.R. Hare W.B. Buck Malignant hyperthermia-like reaction secondary to ingestion of hops in five dogs J Am Vet Med Assoc 210 1 1997 51-54
50. T.E. Nelson M. Lin G. Zapata-Sudo R.T. Sudo Dantrolene sodium can increase or attenuate activity of skeletal muscle ryanodine receptor calcium release channel. Clinical implications Anesthesiology 84 6 1996 1368-1379
51. R.J. Bagshaw R.H. Cox H. Rosenberg Dantrolene treatment of malignant hyperthermia [letter] J Am Vet Med Assoc 178 1981 1029
52. B.R. Fruen J.R. Mickelson C.F. Louis Dantrolene inhibition of sarcoplasmic reticulum Ca2+ release by direct and specific action at skeletal muscle ryanodine receptors J Biol Chem 272 1997 26965-26971
53. D.B. Brunson K. Hogan P.A. Powers et al. Investigation of the causal mutation for malignant hyperthermia in black Labrador Retrievers [abstract] Canine Pract 23 1998 48a
54. D.H. Dyson M.G. Maxie D. Schnurr Morbidity and mortality associated with anesthetic management in small animal veterinary practice in Ontario J Am Anim Hosp Assoc 34 1998 325-335
55. J.S. Gaynor C.I. Dunlop A.E. Wagner et al. Complications and mortality associated with anesthesia in dogs and cats J Am Anim Hosp Assoc 35 1999 13-17
56. N.H. Dodman L.A. Lamb Survey of small animal anesthetic practice in Vermont J Am Anim Hosp Assoc 28 1992 439-445
57. K.C. Clarke L.W. Hall A survey of anaesthesia in small animal practice. AVA/BSAVA Report J Assoc Vet Anaesth 17 1990 4-10